Cécile Alanio
Cécile Alanio
MD, PhD, Parker Bridge Scholar
Verified email at
Cited by
Cited by
Deep immune profiling of COVID-19 patients reveals patient heterogeneity and distinct immunotypes with implications for therapeutic interventions
D Mathew, JR Giles, AE Baxter, AR Greenplate, JE Wu, C Alanio, ...
Science, 2020
PD-1–expressing tumor-infiltrating T cells are a favorable prognostic biomarker in HPV-associated head and neck cancer
C Badoual, S Hans, N Merillon, C Van Ryswick, P Ravel, N Benhamouda, ...
Cancer research 73 (1), 128-138, 2013
Decade-long leukaemia remissions with persistence of CD4+ CAR T cells
JJ Melenhorst, GM Chen, M Wang, DL Porter, C Chen, MKA Collins, ...
Nature 602 (7897), 503-509, 2022
CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer
EM Bange, NA Han, P Wileyto, JY Kim, S Gouma, J Robinson, ...
Nature medicine 27 (7), 1280-1289, 2021
Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection
EM Anderson, EC Goodwin, A Verma, CP Arevalo, MJ Bolton, ME Weirick, ...
Cell 184 (7), 1858-1864. e10, 2021
Natural variation in the parameters of innate immune cells is preferentially driven by genetic factors
E Patin, M Hasan, J Bergstedt, V Rouilly, V Libri, A Urrutia, C Alanio, ...
Nature immunology 19 (3), 302-314, 2018
Enumeration of human antigen–specific naive CD8+ T cells reveals conserved precursor frequencies
C Alanio, F Lemaitre, HKW Law, M Hasan, ML Albert
Blood, The Journal of the American Society of Hematology 115 (18), 3718-3725, 2010
CD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: an open-label …
MH O'Hara, EM O'Reilly, G Varadhachary, RA Wolff, ZA Wainberg, AH Ko, ...
The lancet oncology 22 (1), 118-131, 2021
Deep Immune Profiling of MIS-C demonstrates marked but transient immune activation compared to adult and pediatric COVID-19
EJW Laura Vella,..., Cécile Alanio, ...
MedRxiv, 2020
Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial
LJ Padrón, DM Maurer, MH O’Hara, EM O’Reilly, RA Wolff, ZA Wainberg, ...
Nature medicine 28 (6), 1167-1177, 2022
Human genetic variants and age are the strongest predictors of humoral immune responses to common pathogens and vaccines
P Scepanovic, C Alanio, C Hammer, F Hodel, J Bergstedt, E Patin, ...
Genome medicine 10, 1-13, 2018
A comprehensive assessment of demographic, environmental, and host genetic associations with gut microbiome diversity in healthy individuals
P Scepanovic, F Hodel, S Mondot, V Partula, A Byrd, C Hammer, C Alanio, ...
Microbiome 7, 1-15, 2019
The Milieu Intérieur study—an integrative approach for study of human immunological variance
S Thomas, V Rouilly, E Patin, C Alanio, A Dubois, C Delval, LG Marquier, ...
Clinical immunology 157 (2), 277-293, 2015
Neoadjuvant selicrelumab, an agonist CD40 antibody, induces changes in the tumor microenvironment in patients with resectable pancreatic cancer
KT Byrne, CB Betts, R Mick, S Sivagnanam, DL Bajor, DA Laheru, ...
Clinical Cancer Research 27 (16), 4574-4586, 2021
Modulation of macrophage activation state protects tissue from necrosis during critical limb ischemia in thrombospondin-1-deficient mice
N Bréchot, E Gomez, M Bignon, J Khallou-Laschet, M Dussiot, A Cazes, ...
PloS one 3 (12), e3950, 2008
UPenn COVID Processing Unit
D Mathew, JR Giles, AE Baxter, DA Oldridge, AR Greenplate, JE Wu, ...
Deep immune profiling of COVID-19 patients reveals distinct immunotypes with …, 2020
Pembrolizumab for B-cell lymphomas relapsing after or refractory to CD19-directed CAR T-cell therapy
EA Chong, C Alanio, J Svoboda, SD Nasta, DJ Landsburg, SF Lacey, ...
Blood, The Journal of the American Society of Hematology 139 (7), 1026-1038, 2022
Bystander hyperactivation of preimmune CD8+ T cells in chronic HCV patients
C Alanio, F Nicoli, P Sultanik, T Flecken, B Perot, D Duffy, E Bianchi, ...
Elife 4, e07916, 2015
CD8 T cells compensate for impaired humoral immunity in COVID-19 patients with hematologic cancer
EM Bange, NA Han, P Wileyto, JY Kim, S Gouma, J Robinson, ...
Research square, 2021
Cytomegalovirus latent infection is associated with an increased risk of COVID-19-related hospitalization
C Alanio, A Verma, D Mathew, S Gouma, G Liang, T Dunn, DA Oldridge, ...
The Journal of infectious diseases 226 (3), 463-473, 2022
The system can't perform the operation now. Try again later.
Articles 1–20